RGS18 acts as a negative regulator of osteoclastogenesis by modulating the acid-sensing OGR1/NFAT signaling pathway

Journal of Bone and Mineral Research

Volumn 22, Issue 10, 2007, Pages 1612-1620

  Iwai, Kaori ^a   Koike, Masato ^b   Ohshima, Shiro ^a   Miyatake, Kunio ^c   Uchiyama, Yasuo ^b   Saeki, Yukihiko ^a   Ishii, Masaru ^a,c  

^a NATIONAL HOSPITAL ORGANIZATION   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c MINAMI OSAKA GENERAL HOSPITAL   (Japan)

Author keywords

Acidosis; G protein; OGR1; Osteoclast; Regulator of G protein signaling protein

Indexed keywords

ANTIBODY; COLONY STIMULATING FACTOR 1; GUANOSINE TRIPHOSPHATE; MESSENGER RNA; OSTEOCLAST DIFFERENTIATION FACTOR; POLYCLONAL ANTIBODY; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; REGULATOR OF G PROTEIN SIGNALING 18; REGULATOR PROTEIN; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTION FACTOR NFAT C1; UNCLASSIFIED DRUG; ACID; G PROTEIN COUPLED RECEPTOR; GPR68 PROTEIN, MOUSE; GUANINE NUCLEOTIDE BINDING PROTEIN; PROTEIN SUBUNIT; RGS18 PROTEIN, MOUSE; SIGNAL PEPTIDE;

ACIDOSIS; ANIMAL CELL; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL LINE; CELL LINEAGE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CULTURE MEDIUM; HYDROLYSIS; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MONOCYTE; NONHUMAN; OSTEOCLAST; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; STEM CELL; ANIMAL; BONE; BONE DEVELOPMENT; CELL NUCLEUS; CYTOLOGY; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOUSE; PH;

ACIDS; ANIMALS; BONE AND BONES; CELL NUCLEUS; CELLS, CULTURED; GENE EXPRESSION REGULATION; GTP-BINDING PROTEINS; HYDROGEN-ION CONCENTRATION; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; NFATC TRANSCRIPTION FACTORS; OSTEOCLASTS; OSTEOGENESIS; PROTEIN SUBUNITS; RANK LIGAND; RECEPTORS, G-PROTEIN-COUPLED; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION;

EID: 34548560654     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.070612     Document Type: Article

References (34)

1. Teitelbaum SL 2000 Bone resorption by osteoclasts. Science 289:1504-1508.
2. Teitelbaum SL, Ross FP 2003 Genetic regulation of osteoclast development and function. Nat Rev Genet 4:638-649.
3. Boyle WJ, Simonet WS, Lacey DL 2003 Osteoclast differentiation and activation. Nature 423:337-342.
4. Takayanagi H, Kim S, Koga T, Nishina H, Isshiki M, Yoshida H, Saiura A, Isobe M, Yokochi T, Inoue J, Wagner EF, Mak TW, Kodama T, Taniguchi T 2002 Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev Cell 3:889-901.
5. Ishida N, Hayashi K, Hoshijima M, Ogawa T, Koga S, Miyatake Y, Kumegawa M, Kimura T, Takeya T 2002 Large scale gene expression analysis of osteoclastogenesis in vitro and elucidation of NFAT2 as a key regulator. J Biol Chem 277:41147-41156.
6. Komarova SV, Pereverzev A, Shum JW, Sims SM, Dixon SJ 2005 Convergent signaling by acidosis and receptor activator of NF-κB (RANKL) on the calcium/calcineurin/NFAT pathway in osteoclasts. Proc Natl Acad Sci USA 102:2643-2648.
7. Yang M, Mailhot G, Birnbaum MJ, MacKay CA, Mason-Savas A, Odgren PR 2006 Expression of and role for ovarian cancer G-protein-coupled receptor (OGR1) during osteoclastogenesis. J Biol Chem 281:23598-23605.
8. Ludwig M-G, Vanek M, Guerini D, Gasser JA, Jones CE, Junker U, Hofstetter H, Wolf RM, Seuwen K 2003 Protonsensing G-protein-coupled receptors. Nature 425:93-98.
9. Gilman AG 1987 G proteins: Transducers of receptor-generated signals. Annu Rev Biochem 56:615-649.
10. i3, is a member of a protein family with a highly conserved core domain. Proc Natl Acad Sci USA 92:11916-11920.
11. Berman DM, Wilkie TM, Gilman AG 1996 GAIP and RGS4 are GTPase-activating proteins for the Gi subfamily of G protein alpha subunits. Cell 86:445-452.
12. Ross EM, Wilkie TM 2000 GTPase-activating proteins for heterotrimeric G proteins: Regulators of G protein signaling (RGS) and RGS-like proteins. Annu Rev Biochem 69:795-827.
13. Neubig RR, Siderovski DP 2002 Regulators of G-protein signalling as new central nervous system drug targets. Nat Rev Drug Discov 1:187-197.
14. Ishii M, Kurachi Y 2003 Physiological actions of regulators of G-protein signaling (RGS) proteins. Life Sci 74:163-171.
15. Kehrl JH 1998 Heterotrimeric G protein signaling: Roles in immune function and fine-tuning by RGS proteins. Immunity 8:1-10.
16. Beadling C, Druey KM, Richter G, Kehrl JH, Smith KA 1999 Regulators of G protein signaling exhibit distinct patterns of gene expression and target G protein specificity in human lymphocytes. J Immunol 162:2677-2682.
17. Denecke B, Meyerdierks A, Bottger EC 1999 RGS1 is expressed in monocytes and acts as a GTPase-activating protein for G-protein-coupled chemoattractant receptors. J Biol Chem 274:26860-26868.
18. Reif K, Cyster JG 2000 RGS molecule expression in murine B lymphocytes and ability to down-regulate chemotaxis to lymphoid chemokines. J Immunol 164:4720-4729.
19. Berthebaud M, Riviere C, Jarrier P, Foudi A, Zhang Y, Compagno D, Galy A, Vainchenker W, Louache F 2005 RGS16 is a negative regulator of SDF-1-CXCR4 signaling in megakaryocytes. Blood 106:2962-2968.
20. Kobayashi K, Takahashi N, Jimi E, Udagawa N, Takami M, Kotake S, Nakagawa N, Kinosaki M, Yamaguchi K, Shima N, Yasuda H, Morinaga T, Higashio K, Martin TJ, Suda T 2000 Tumor necrosis factor α stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction. J Exp Med 191:275-286.
21. Doupnik CA, Xu T, Shinaman JM 2001 Profile of RGS expression in single rat atrial myocytes. Biochim Biophys Acta 1552:97-107.
22. Ishii M, Iwai K, Koike M, Ohshima S, Kudo-Tanaka E, Ishii T, Mima T, Katada Y, Miyatake K, Uchiyama Y, Saeki Y 2006 RANKL-induced expression of tetraspanin CD9 in lipid raft membrane microdomain is essential for cell fusion during osteoclastogenesis. J Bone Miner Res 21:965-976.
23. Filgueira L 2004 Fluorescence-based staining for tartrate-resistant acidic phosphatase (TRAP) in osteoclasts combined with other fluorescent dyes and protocols. J Histochem Cytochem 52:411-414.
24. Park LK, Klug CA, Li K, Jerabek L, Li L, Nanamori M, Neubig RR, Hood L, Weissman IL, Clarke MF 2001 Molecular cloning and characterization of a novel regulator of G-protein signaling from mouse hematopoietic stem cells. J Biol Chem 276:915-923.
25. Nagata Y, Oda M, Nakata H, Shozaki Y, Kozasa T, Todokoro K 2001 A novel regulator of G-protein signaling bearing GAP activity for Gαi and Gαq in megakaryocytes. Blood 97:3051-3060.
26. Yowe D, Weich N, Prabhudas M, Poisson L, Errada P, Kapeller R, Yu K, Faron L, Shen M, Cleary J, Wilkie TM, Gutierrez-Ramos C, Hodge MR 2001 RGS18 is a myeloerythroid lineage-specific regulator of G-protein-signaling molecule highly expressed in megakaryocytes. Biochem J 359:109-118.
27. Katada T, Ui M 1982 ADP ribosylation of the specific membrane protein of C6 cells by islet-activating protein associated with modification of adenylate cyclase activity. J Biol Chem 257:7210-7216.
28. Bokoch GM, Katada T, Northup JK, Ui M, Gilman AG 1984 Purification and properties of the inhibitory guanine nucleotide-binding regulatory component of adenylate cyclase. J Biol Chem 259:3560-3567.
29. Sun-Wada GH, Wada Y, Futai M 2004 Diverse and essential roles of mammalian vacuolar-type proton pump ATPase: Toward the physiological understanding of inside acidic compartments. Biochim Biophys Acta 1658:106-114.
30. Blair HC, Athanasou NA 2004 Recent advances in osteoclast biology and pathological bone resorption. Histol Histopathol 19:189-199.
31. + channel. Proc Natl Acad Sci USA 99:4325-4330.
32. Ishii M, Kurachi Y 2004 Assay of RGS protein modulation by phosphatidylinositides and calmodulin. Methods Enzymol 389:105-118.
33. Yang S, Li Y-P 2007 RGS12 is essential for RANKL-evoked signaling for terminal differentiation of osteoclasts in vitro. J Bone Miner Res 22:45-54.
34. Grillet N, Dubreuil V, Dufour HD, Brunet JF 2003 Dynamic expression of RGS4 in the developing nervous system and regulation by the neural type-specific transcription factor Phox2b. J Neurosci 23:10613-10621.